Tilray sees positive ebitda in q4 2020; may tap debt markets soon - conf. call

Will likely transition reporting key operating metrics to focus on units as grams become "less relevant" in cannabis 2.0 - conf. call.continue to expect gross margin to increase sequentially going forward.will likely tap the debt markets in the next coming quarters.inventory balances have increased during quarter.continue to believe co has sufficient capital and access to capital until achieving positive ebitda.expects to achieve positive ebitda in q4 2020.expect quarterly cash burn will decrease each quarter going forward.expect inventory levels to start to decrease throughout 2020.tilray says fluent-ab inbev partnership will launch products in december.fluent-ab inbev partnership will launch cbd beverages for sale in canada in december.expect significant increases in international medical business to offest any risk on canadian adult-use market.sees over 40% margins in 2020 for fy.expect price per gram to be going up from here.international medical will be bigger mix of overall revenue as well as 2.0 products will be bigger mix of overall revenues going forward.getting close to supply demand balance on low quality by-product and for low potency product."for high potency products and products that consumers want, there's just not enough supply" - ceo.
TLRY Ratings Summary
TLRY Quant Ranking